Sonic Healthcare (ASX:SHL) today reported a statutory net profit for the year to 30 June 2018 of $476 million, rise of 11.2 per cent.
They saw revenue growth of 8.2 per cent to $5.5 billion.
Underlying EBITDA growth 6.4 per cent of constant currency.
Final dividend up 6.5 per cent to $0.49 per share.
One of the milestones for the year for the company was winning the national bowel screening program contract for Australia.
Shares in Sonic Healthcare (ASX:SHL) closed 2.02 per cent higher to $26.78.